Epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease.
Recruiting
18 years - 80 years
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to collect information about the blood level of a specific marker (lipoprotein (a)). Similar to other blood lipids, such as the "bad cholesterol", lipoprotein (a) levels were found to be associated with the risk of hardening of the arteries, known as atherosclerosis, which leads to conditions such as heart attacks, stroke, or peripheral artery disease (severe pain in legs while walking or lower limb amputation.)
In this study which is performed on a global scale, we will collect information from patients with these conditions to better understand what the lipoprotein (a) levels are over a broad geography.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cardiovascular disease,heart attack,stroke,peripheral arterial disease,elevated lipoprotein (a)
-
Age: 18 years - 80 years
-
Gender: All
- History of heart attack OR
- History of stroke OR
- Peripheral arterial disease
Updated on
19 Feb 2024.
Study ID: 833997
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or